Abstract |
A double-blind, placebo-controlled study of mefloquine antimalarial prophylaxis in pregnancy (> 20 weeks of gestation) was conducted in 339 Karen women living in an area of multidrug-resistant malaria transmission on the Thai-Burmese border. Mefloquine gave > or = 86% (95% confidence interval [CI], 59%-94%) protection against Plasmodium falciparum and complete protection against Plasmodium vivax infections. Mefloquine prophylaxis was well tolerated; use of an initial loading dose (10 mg/kg) was associated with transient dizziness, but there were no other significant adverse effects on the mother, the pregnancy, or infant survival or development (followed for 2 years). Falciparum malaria was associated with maternal anemia and a mean reduction in birth weight in gravidae I, II, and III of 225 g (95% CI, 26-423). Maternal anemia at delivery (hematocrit < 30%) was associated with increased infant mortality: 26% versus 15% (relative risk, 1.9; 95% CI, 1.1-3.2). Mefloquine is safe and effective for antimalarial prophylaxis in the second half of pregnancy.
|
Authors | F Nosten, F ter Kuile, L Maelankiri, T Chongsuphajaisiddhi, L Nopdonrattakoon, S Tangkitchot, E Boudreau, D Bunnag, N J White |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 169
Issue 3
Pg. 595-603
(Mar 1994)
ISSN: 0022-1899 [Print] United States |
PMID | 8158032
(Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adult
- Anemia
(prevention & control)
- Double-Blind Method
- Drug Resistance
- Female
- Follow-Up Studies
- Humans
- Infant, Newborn
- Malaria
(physiopathology, prevention & control)
- Malaria, Falciparum
(prevention & control)
- Malaria, Vivax
(prevention & control)
- Mefloquine
(adverse effects, therapeutic use)
- Myanmar
(epidemiology)
- Outcome Assessment, Health Care
- Placenta
(parasitology)
- Pregnancy
- Pregnancy Complications, Parasitic
(prevention & control)
- Thailand
(epidemiology)
|